The SULF-FAST is a clinical decision rule adapted from PEN-FAST for assessing the risk of true allergy in patients with reported trimethoprim-sulfamethoxazole (sulfa) allergy. It helps determine if delabeling or rechallenge is safe.
The SULF-FAST Score is calculated by adding the selected points:
Variable | Points |
---|---|
Five years or less since reaction | No: 0 Yes/unknown: 2 |
Anaphylaxis or angioedema OR Severe cutaneous adverse reaction* |
No: 0 Yes: 2 |
Treatment required for reaction | No: 0 Yes/unknown: 1 |
*Severe cutaneous reactions may include Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, and acute generalized exanthematous pustulosis. Patients with a severe delayed rash with mucosal involvement should be considered to have a severe cutaneous adverse reaction.
Total score ranges from 0 to 7. Select Yes/No for each criterion and calculate.
Note: Used for adults with reported sulfa allergy; consult specialist for complex cases.
This calculator assists clinicians in risk-stratifying patients with labeled sulfa allergies to guide safe delabeling or rechallenge without specialist referral.
Select presence of each criterion. The calculator outputs the score and risk interpretation.
Example 1: >5 years ago, no anaphylaxis, no SCAR, no treatment.
Example 2: ≤5 years, anaphylaxis, SCAR yes, treatment yes.
Use in conjunction with clinical judgment.
Below are frequently asked questions about SULF-FAST Score:
The SULF-FAST helps identify low-risk patients for safe delabeling but should not replace clinical judgment. For low scores (<3), direct oral challenge may be appropriate. For higher scores, refer to allergy specialist.
Interpretation:
SULF-FAST Score | Risk of True Antimicrobial Sulfonamide Allergy |
---|---|
<3 | <5% (low risk) |
≥3 | >20% (elevated risk) |
Evidence from validation studies shows high NPV for low-risk classification.
Consider patient history and comorbidities.